Results 91 to 100 of about 7,331 (198)

Ivabradine and the SIGNIFY conundrum [PDF]

European Heart Journal, 2015
This editorial refers to ‘Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study’[†][1], by K. Fox et al ., on page 3291. Stable angina is a prevalent and disabling condition that occurs in 10–14% of those aged 65–84 years,1 with population studies suggesting ...
openaire   +3 more sources

Absence of respiratory effects with ivabradine in patients with asthma.

, 2008
What is already known about this subject* Ivabradine is a new heart rate-lowering agent that acts specifically on the sinoatrial node via the I(f) pacemaker channels. * Ivabradine has demonstrated similar efficacy to beta-blockers. * As beta-blockers are
Gadzik, Frantisek, Babu, K. Suresh, Stephen T. Holgate, Holgate, Stephen T., K. Suresh Babu, Frantisek Gadzik   +5 more
core   +1 more source

The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients

Rambam Maimonides Medical Journal, 2015
Background: Postural tachycardia syndrome (POTS) is a common form of chronic orthostatic intolerance. The remarkable increase in heart rate (HR) upon standing is the hallmark of this syndrome.
Merav Barzilai, Giris Jacob
doaj   +1 more source

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function

Clinics and Practice, 2013
Multicenter trials have demonstrated that in patients with sinus rhythm ivabradine is effective in the therapy of ischemic heart disease and of impaired left ventricular systolic function. Ivabradine is ineffective in atrial fibrillation.
Giuseppe Cocco, Paul Jerie
doaj   +1 more source

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure

The Egyptian Heart Journal, 2011
Background: The aim of this study was to investigate the effect of ivabradine on symptoms, quality of life, effort tolerance, and echocardiographic parameters in patients with idiopathic dilated cardiomyopathy presenting with New York Heart Association ...
Sherief Mansour, Amr Youssef, Mona Rayan, M. Ayman Saleh   +3 more
doaj   +1 more source

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS

Российский кардиологический журнал, 2018
The review is focused on the role of ivabradine in percutaneous coronary intervention (PCI) and coronary bypass grafting (CBG) in coronary heart disease patients (CHD) with stable angina.
D. M. Aronov, M. G. Bubnova
doaj   +1 more source

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE

Pakistan Armed Forces Medical Journal, 2020
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular failure patients. Study Design: Quasi experimental study.
Safia Batool, Jamal Waris, Muhammad Usman Sajid, Shazia Nisar, Imran Khan, Hina Mushtaq   +5 more
doaj  

Ivabradine: Heart Failure and Beyond

, 2015
Heart failure affects over 5 million people in the United States and carries a high rate of mortality. Ivabradine, a new agent has been added to the current medical options for managing heart failure.
Martinez, Matthew W, MD, Lanier, Gregg, Shah, Neeraj, MD, Garg, Jalaj, MD, Krishnamoorthy, Parasuram, MD, Freudenberger, Ronald S, MD, Chaudhary, Rahul, MD   +6 more
core  

Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering

, 2017
Ivabradine is a heart rate reducing agent that exhibits anti-ischemic effects through the inhibition of funny electrical current in the sinus node resulting in heart rate reduction, thus enabling longer diastolic perfusion time, and reduced myocardial ...
Crea, Filippo, Giampaolo Niccoli, Filippo Crea, Borovac, Josip AnÄ‘elo, Niccoli, Giampaolo, Vetrugno, Vincenzo, Josip Anđelo Borovac, Vincenzo Vetrugno, Paolo G Camici, CAMICI, PAOLO   +9 more
core   +1 more source

Fatal intoxication with ivabradine: First case report

, 2020
International audienceIvabradine is a bradycardic drug used worldwide in the treatment of chronic stable angina and chronic heart failure. We presented here a case of a 61-year-old woman who was admitted to emergency department for overdose.
Zerah, M., Alvarez, J.-C., Mayer-Duverneuil, C., de La Grandamison, G. Lorin, Knapp-Gisclon, A., Rambaud, C.   +5 more
core   +1 more source